arrow
Return

BETA: a comprehensive benchmark for computational drug-target prediction

delete2022-06-02
delete8
delete
OA
AI
N
Nansu Zong *
李宁 (Ning Li)
A
Andrew Wen
V
Victoria Ngo
Y
Yue Yu
M
Ming Huang
S
Shaika Chowdhury
C
Chao Jiang
S
Sunyang Fu
R
Richard M. Weinshilboum
G
Guoqian Jiang
L
Lawrence Hunter
H
Hongfang Liu
DOI:10.1093/bib/bbac199delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Internal validation is the most popular evaluation strategy used for drug-target predictive models. The simple random shuffling in the cross-validation, however, is not always ideal to handle large, diverse and copious datasets as it could potentially introduce bias. Hence, these predictive models cannot be comprehensively evaluated to provide insight into their general performance on a variety of use-cases (e.g. permutations of different levels of connectiveness and categories in drug and target space, as well as validations based on different data sources). In this work, we introduce a benchmark, BETA, that aims to address this gap by (i) providing an extensive multipartite network consisting of 0.97 million biomedical concepts and 8.5 million associations, in addition to 62 million drug-drug and protein-protein similarities and (ii) presenting evaluation strategies that reflect seven cases (i.e. general, screening with different connectivity, target and drug screening based on categories, searching for specific drugs and targets and drug repurposing for specific diseases), a total of seven Tests (consisting of 344 Tasks in total) across multiple sampling and validation strategies. Six state-of-the-art methods covering two broad input data types (chemical structure- and gene sequence-based and network-based) were tested across all the developed Tasks. The best-worst performing cases have been analyzed to demonstrate the ability of the proposed benchmark to identify limitations of the tested methods for running over the benchmark tasks. The results highlight BETA as a benchmark in the selection of computational strategies for drug repurposing and target discovery.
Keywords:
computational cenchmark
drug target prediction
computational drug development
deep learning
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Briefings in Bioinformatics cover
Briefings in Bioinformatics
IF:
7.7
Papers:
5.6K
Citations:
2.7W

Organization

VA Palo Alto Health Care System cover
VA Palo Alto Health Care System
Scholars:
1.8K
Papers: 1.5K
Citations: 5.6K
N
national institutes of health (nih) - usa
Scholars:
10.3W
Papers: 8.2W
Citations: 111
A
Auburn University
Scholars:
7.2K
Papers: 5.8K
Citations: 1.3W
M
mayo clinic
Scholars:
8.2W
Papers: 6.5W
Citations: 85
A
auburn university system
Scholars:
1.1W
Papers: 9.5K
Citations: 9
V
veterans health administration (vha)
Scholars:
2.6W
Papers: 2.1W
Citations: 40
N
nih national cancer institute (nci)
Scholars:
2.1W
Papers: 1.6W
Citations: 27
researcher View more organizations